Logo image of DYAI

DYADIC INTERNATIONAL INC (DYAI) Stock Fundamental Analysis

NASDAQ:DYAI - Nasdaq - US26745T1016 - Common Stock - Currency: USD

0.9892  -0.01 (-1.07%)

Fundamental Rating

2

DYAI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 557 industry peers in the Biotechnology industry. DYAI may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, DYAI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year DYAI has reported negative net income.
DYAI had a negative operating cash flow in the past year.
In the past 5 years DYAI always reported negative net income.
In the past 5 years DYAI always reported negative operating cash flow.
DYAI Yearly Net Income VS EBIT VS OCF VS FCFDYAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

The Return On Assets of DYAI (-73.81%) is worse than 66.07% of its industry peers.
With a Return On Equity value of -630.92%, DYAI is not doing good in the industry: 79.89% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -73.81%
ROE -630.92%
ROIC N/A
ROA(3y)-70.74%
ROA(5y)-60.92%
ROE(3y)-146.19%
ROE(5y)-108.49%
ROIC(3y)N/A
ROIC(5y)N/A
DYAI Yearly ROA, ROE, ROICDYAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

Looking at the Gross Margin, with a value of 62.06%, DYAI is in the better half of the industry, outperforming 79.53% of the companies in the same industry.
In the last couple of years the Gross Margin of DYAI has grown nicely.
The Profit Margin and Operating Margin are not available for DYAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y50.87%
GM growth 5Y38.12%
DYAI Yearly Profit, Operating, Gross MarginsDYAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K 20K

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for DYAI has been increased compared to 1 year ago.
DYAI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DYAI is higher compared to a year ago.
DYAI Yearly Shares OutstandingDYAI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
DYAI Yearly Total Debt VS Total AssetsDYAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

DYAI has an Altman-Z score of -14.10. This is a bad value and indicates that DYAI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -14.10, DYAI is not doing good in the industry: 79.35% of the companies in the same industry are doing better.
DYAI has a Debt/Equity ratio of 5.40. This is a high value indicating a heavy dependency on external financing.
DYAI has a worse Debt to Equity ratio (5.40) than 83.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.4
Debt/FCF N/A
Altman-Z -14.1
ROIC/WACCN/A
WACCN/A
DYAI Yearly LT Debt VS Equity VS FCFDYAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

DYAI has a Current Ratio of 3.98. This indicates that DYAI is financially healthy and has no problem in meeting its short term obligations.
DYAI has a Current ratio (3.98) which is comparable to the rest of the industry.
DYAI has a Quick Ratio of 3.98. This indicates that DYAI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.98, DYAI is in line with its industry, outperforming 47.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.98
Quick Ratio 3.98
DYAI Yearly Current Assets VS Current LiabilitesDYAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 28.57% over the past year.
DYAI shows a strong growth in Revenue. In the last year, the Revenue has grown by 57.20%.
The Revenue has been growing by 15.78% on average over the past years. This is quite good.
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)57.2%
Revenue growth 3Y13.35%
Revenue growth 5Y15.78%
Sales Q2Q%14.71%

3.2 Future

DYAI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.77% yearly.
DYAI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.64% yearly.
EPS Next Y3.1%
EPS Next 2Y17.81%
EPS Next 3Y16.77%
EPS Next 5YN/A
Revenue Next Year-2.33%
Revenue Next 2Y13.1%
Revenue Next 3Y17.64%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
DYAI Yearly Revenue VS EstimatesDYAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
DYAI Yearly EPS VS EstimatesDYAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.1 -0.2 -0.3 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DYAI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DYAI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DYAI Price Earnings VS Forward Price EarningsDYAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DYAI Per share dataDYAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1

4.3 Compensation for Growth

DYAI's earnings are expected to grow with 16.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.81%
EPS Next 3Y16.77%

More info and screens

0

5. Dividend

5.1 Amount

DYAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DYADIC INTERNATIONAL INC

NASDAQ:DYAI (7/11/2025, 8:06:26 PM)

0.9892

-0.01 (-1.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-11 2025-08-11
Inst Owners16.81%
Inst Owner Change0%
Ins Owners17.69%
Ins Owner Change0.26%
Market Cap29.77M
Analysts82.86
Price Target9.18 (828.02%)
Short Float %0.71%
Short Ratio3.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)40.63%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-43.62%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.37
P/FCF N/A
P/OCF N/A
P/B 32.23
P/tB 32.23
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.12
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -73.81%
ROE -630.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.06%
FCFM N/A
ROA(3y)-70.74%
ROA(5y)-60.92%
ROE(3y)-146.19%
ROE(5y)-108.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y50.87%
GM growth 5Y38.12%
F-Score3
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 5.4
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.98
Quick Ratio 3.98
Altman-Z -14.1
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y3.1%
EPS Next 2Y17.81%
EPS Next 3Y16.77%
EPS Next 5YN/A
Revenue 1Y (TTM)57.2%
Revenue growth 3Y13.35%
Revenue growth 5Y15.78%
Sales Q2Q%14.71%
Revenue Next Year-2.33%
Revenue Next 2Y13.1%
Revenue Next 3Y17.64%
Revenue Next 5YN/A
EBIT growth 1Y30.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y35.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.16%
OCF growth 3YN/A
OCF growth 5YN/A